Olympus has released PSA and fPSA assays for the Olympus AU3000i immunoassay analyser. The assays feature assay sensitivity of 0.015 µg/L. In the monitoring of patients after prostate cancer treatment, the sensitive PSA assay is suitable for the detection of recurrence of the disease.
The assays use a two-step immunometric design, minimising the risk of high-dose-hook and ensuring that the measurement of samples with elevated PSA levels will generate appropriate results. No high-dose-hook has been observed at PSA concentrations up to 160,000 µg/L, according to Olympus.
Other available test panels for the AU30001 include the primary tumour marker panel (AFP, CEA, PSA and fPSA) and the specialist tumour markers GI TN-TC and BR-TC.
Phone: 03 9265 5400
Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit
The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...
Invent Biotechnologies Minute Single Cell Nuclei Kits
The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...
